575 filings
Page 5 of 29
6-K
qxi8pmn45snq4
16 Mar 21
Current report (foreign)
1:15pm
6-K
r72k94suc9jm xy4
11 Mar 21
Announces the Initiation of Its Preclinical Program for the Potential
8:30am
6-K
o4ms9t0bk
9 Mar 21
Current report (foreign)
7:00am
6-K
eps k3lan
18 Feb 21
Current report (foreign)
4:05pm
6-K
vtv3vg e8dh
2 Feb 21
Current report (foreign)
7:40am
6-K
2uq9 0uood219n
28 Jan 21
Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics
4:05pm
6-K
4l7gndxrkcmaalfp
26 Jan 21
Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
5:30pm
6-K
dzfwf
7 Dec 20
Current report (foreign)
8:15am
6-K
8co tjuwjqgc0a9tahlr
16 Nov 20
Current report (foreign)
8:15am
6-K
pdujyjof05yp mbd
5 Nov 20
Condensed Interim Consolidated Financial Statements
4:32pm
6-K
ccyyd f17f89wcfxz
7 Oct 20
Current report (foreign)
9:11am
6-K
54r09a393fjpegvde5s
5 Aug 20
Condensed Interim Consolidated Financial Statements
9:02pm
6-K
riev9c8
5 Aug 20
Current report (foreign)
9:22am
6-K
z9te1
4 Aug 20
Aeterna Zentaris Announces $7.0 Million Registered Direct Offering priced at-the-market
12:00am
6-K
qe2nb6dn8 hnf
31 Jul 20
Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications
8:51am
6-K
7yn0gn
31 Jul 20
Current report (foreign)
12:00am
6-K
5kq2pydwv5n
29 Jul 20
Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
7:10am
6-K
yhxzn0u9noq kd
6 Jul 20
AETERNA zentaris announces pricing of $12 mIllion public offering
7:00am
6-K
76kn 23clnhqyflrda8
25 Jun 20
AETERNAzentaris ANNOUNCES DISTRIBUTION AGREEMENT
8:05am
6-K
qz3czpog
8 Jun 20
Current report (foreign)
8:30am